Nordic Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.09 Cr
as on 14-12-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.87 Cr
as on 14-12-2024
- Revenue 12.30%
(FY 2023)
- Profit 16.26%
(FY 2023)
- Ebitda 170.18%
(FY 2023)
- Net Worth 3.30%
(FY 2023)
- Total Assets 6.54%
(FY 2023)
About Nordic Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.09 Cr.
The company currently has active open charges totaling ₹2.87 Cr.
Manoj Poddar, Manish Poddar, Banwari Poddar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231UP1999PTC024786
- Company No.
024786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nordic Formulations?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Poddar  | Director | 27-Sep-1999 | Current |
| Manish Poddar | Director | 27-Sep-1999 | Current |
| Banwari Poddar | Director | 09-Dec-2002 | Current |
| Kusum Poddar | Director | 31-Mar-2015 | Current |
| Neelam Poddar | Director | 31-Mar-2015 | Current |
Financial Performance of Nordic Formulations.
Nordic Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.3% increase. The company also saw a substantial improvement in profitability, with a 16.26% increase in profit. The company's net worth moved up by a moderate rise of 3.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nordic Formulations?
In 2023, Nordic Formulations had a public holding of 53.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nordic Pharmaceuticals LimitedActive 27 years 4 monthsManoj Poddar, Manish Poddar and 2 more are mutual person
Alaknanda Cruiseline Private LimitedActive 7 years 8 monthsManoj Poddar, Manish Poddar and 2 more are mutual person
Kewat Hospitalities Private LimitedActive 9 months 2 daysManoj Poddar and Manish Poddar are mutual person
Charges (Loans)
₹2.87 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 2.87 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2020 | Bank Of India | ₹2.95 M | Open |
| 24 Jan 2019 | Bank Of India | ₹0.80 M | Open |
| 09 Sep 2005 | Bank Of India | ₹2.50 Cr | Open |
How Many Employees Work at Nordic Formulations?
Nordic Formulations has a workforce of 92 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nordic Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nordic Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
